ORAMED PHARMACEUTICALS INC. - ORMP
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | President and CEO | F | D | 44,818.0 | 3.31 | 148,347.58 | 3,422,243.0 | View | |
| Mar 31, 2026 | Chief Scientific Officer | F | D | 435,084.0 | 3.31 | 1,440,128.04 | 1,133,138.0 | View | |
| Mar 18, 2026 | COO & CBO | A | A | 95,889.0 | 0.0 | 0.0 | 1,160,384.0 | View | |
| Mar 18, 2026 | President and CEO | A | A | 167,005.0 | 0.0 | 0.0 | 3,422,243.0 | View | |
| Mar 18, 2026 | Chief Scientific Officer | A | A | 119,558.0 | 0.0 | 0.0 | 1,568,222.0 | View | |
| Mar 18, 2026 | Chief Financial Officer | A | A | 95,889.0 | 0.0 | 0.0 | 745,145.0 | View | |
| Mar 16, 2026 | President and CEO | G | D | 100,000.0 | 0.0 | 0.0 | 3,255,238.0 | View | |
| Jan 29, 2026 | Chief Financial Officer | M | D | 19,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 29, 2026 | Chief Financial Officer | M | A | 19,000.0 | 0.0 | 0.0 | 649,256.0 | View | |
| Jan 29, 2026 | Chief Scientific Officer | M | D | 19,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 29, 2026 | Chief Scientific Officer | M | A | 19,000.0 | 0.0 | 0.0 | 1,448,664.0 | View | |
| Jan 29, 2026 | COO & CBO | M | D | 19,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 29, 2026 | COO & CBO | M | A | 19,000.0 | 0.0 | 0.0 | 1,064,495.0 | View | |
| Jan 29, 2026 | President and CEO | M | D | 109,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 29, 2026 | President and CEO | M | A | 109,000.0 | 0.0 | 0.0 | 3,355,238.0 | View | |
| Jan 21, 2026 | Chief Scientific Officer | G | D | 86,166.0 | 0.0 | 0.0 | 1,343,498.0 | View | |
| Jan 05, 2026 | — | A | A | 4,900.0 | — | — | 168,009.0 | View | |
| Jan 05, 2026 | — | A | A | 30,000.0 | — | — | 163,109.0 | View | |
| Jan 05, 2026 | — | A | A | 3,500.0 | — | — | 123,220.0 | View | |
| Jan 05, 2026 | — | A | A | 30,000.0 | — | — | 119,720.0 | View | |
| Jan 05, 2026 | COO & CBO | A | A | 19,000.0 | 0.0 | 0.0 | 19,000.0 | View | |
| Jan 05, 2026 | COO & CBO | A | A | 115,000.0 | 0.0 | 0.0 | 1,045,495.0 | View | |
| Jan 05, 2026 | COO & CBO | A | A | 97,328.0 | 0.0 | 0.0 | 930,495.0 | View | |
| Jan 05, 2026 | Chief Scientific Officer | A | A | 19,000.0 | 0.0 | 0.0 | 19,000.0 | View | |
| Jan 05, 2026 | Chief Scientific Officer | A | A | 115,000.0 | 0.0 | 0.0 | 1,429,664.0 | View | |
| Jan 05, 2026 | Chief Scientific Officer | A | A | 121,331.0 | 0.0 | 0.0 | 1,314,664.0 | View | |
| Jan 05, 2026 | — | A | A | 6,250.0 | — | — | 105,180.0 | View | |
| Jan 05, 2026 | — | A | A | 30,000.0 | — | — | 98,930.0 | View | |
| Jan 05, 2026 | President and CEO | A | A | 109,000.0 | 0.0 | 0.0 | 109,000.0 | View | |
| Jan 05, 2026 | President and CEO | A | A | 327,000.0 | 0.0 | 0.0 | 3,246,238.0 | View | |
| Jan 05, 2026 | President and CEO | A | A | 232,640.0 | 0.0 | 0.0 | 2,919,238.0 | View | |
| Jan 02, 2026 | — | A | A | 6,250.0 | — | — | 113,441.0 | View | |
| Jan 02, 2026 | — | A | A | 30,000.0 | — | — | 107,191.0 | View | |
| Jan 02, 2026 | Chief Financial Officer | A | A | 19,000.0 | 0.0 | 0.0 | 19,000.0 | View | |
| Jan 02, 2026 | Chief Financial Officer | A | A | 115,000.0 | 0.0 | 0.0 | 630,256.0 | View | |
| Jan 02, 2026 | Chief Financial Officer | A | A | 81,216.0 | 0.0 | 0.0 | 515,256.0 | View |